Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Guofeng Huayang Pharmaceutical is a specialized pharmaceutical subsidiary of the Qingdao Guofeng Pharmaceutical Group, which is a member of the Shanghai Pharmaceuticals Holding network. The company focuses on the development and large-scale manufacturing of both modern chemical drugs and Traditional Chinese Medicine (TCM) preparations. It is most notably recognized for its production of Polysaccharide Iron Complex capsules under the brand name Hongyuan, which is a leading treatment for iron-deficiency anemia in the Chinese market. Operating from its GMP-certified facilities in Qingdao, the company provides a wide range of therapeutic solutions covering cardiovascular, respiratory, and metabolic health. As part of a major state-owned pharmaceutical conglomerate, it integrates research, production, and distribution to serve the domestic healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Guofeng Group Huayang Pharmaceutical.